    <SEC-DOCUMENT>0001193125-23-125223-index.html : 20230428
    <SEC-HEADER>0001193125-23-125223.hdr.sgml : 20230428
    <ACCEPTANCE-DATETIME>20230428111907
    ACCESSION NUMBER:		0001193125-23-125223
    CONFORMED SUBMISSION TYPE:	ARS
    PUBLIC DOCUMENT COUNT:		1
    CONFORMED PERIOD OF REPORT:	20221231
    FILED AS OF DATE:		20230428
    DATE AS OF CHANGE:		20230428
    EFFECTIVENESS DATE:		20230428

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			ACHIEVE LIFE SCIENCES, INC.
    		CENTRAL INDEX KEY:			0000949858
    		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
    		IRS NUMBER:				954343413
    		STATE OF INCORPORATION:			DE
    		FISCAL YEAR END:			1231

    	FILING VALUES:
    		FORM TYPE:		ARS
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	033-80623
    		FILM NUMBER:		23861801

    	BUSINESS ADDRESS:
    		STREET 1:		22722 29TH DR. SE
    		STREET 2:		SUITE 100
    		CITY:			SEATTLE
    		STATE:			WA
    		ZIP:			98021
    		BUSINESS PHONE:		425-686-1500

    	MAIL ADDRESS:
    		STREET 1:		22722 29TH DR. SE
    		STREET 2:		SUITE 100
    		CITY:			SEATTLE
    		STATE:			WA
    		ZIP:			98021

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	ONCOGENEX PHARMACEUTICALS, INC.
    		DATE OF NAME CHANGE:	20080821

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	SONUS PHARMACEUTICALS INC
    		DATE OF NAME CHANGE:	19950825
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>ARS
    <SEQUENCE>1
    <FILENAME>d466288dars.pdf
    <DESCRIPTION>ARS
    <TEXT>
    Document 1 - file: d466288dars.pdf

    </DOCUMENT>
    </SEC-DOCUMENT>